Your browser doesn't support javascript.
loading
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer.
Huntington, Kelsey E; Louie, Anna D; Srinivasan, Praveen R; Schorl, Christoph; Lu, Shaolei; Silverberg, David; Newhouse, Daniel; Wu, Zhijin; Zhou, Lanlan; Borden, Brittany A; Giles, Francis J; Dooner, Mark; Carneiro, Benedito A; El-Deiry, Wafik S.
Afiliação
  • Huntington KE; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Louie AD; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Srinivasan PR; The Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, Providence, Rhode Island, USA.
  • Schorl C; Legorreta Cancer Center at Brown University, Warren Alpert Medical School, Brown University, Providence, Providence, Rhode Island, USA.
  • Lu S; Pathobiology Graduate Program, Brown University, Providence, Rhode Island, USA.
  • Silverberg D; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Newhouse D; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Wu Z; The Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, Providence, Rhode Island, USA.
  • Zhou L; Legorreta Cancer Center at Brown University, Warren Alpert Medical School, Brown University, Providence, Providence, Rhode Island, USA.
  • Borden BA; Department of Surgery, Lifespan Health System and Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Giles FJ; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Dooner M; Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Carneiro BA; The Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, Providence, Rhode Island, USA.
  • El-Deiry WS; Legorreta Cancer Center at Brown University, Warren Alpert Medical School, Brown University, Providence, Providence, Rhode Island, USA.
bioRxiv ; 2023 Feb 07.
Article em En | MEDLINE | ID: mdl-36798357

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos